Bank of New York Mellon’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,644
| Closed | -$29K | – | 4595 |
|
|
2022
Q1 | $29K | Hold |
3,644
| – | – | ﹤0.01% | 4590 |
|
|
2021
Q4 | $29K | Hold |
3,644
| – | – | ﹤0.01% | 4555 |
|
|
2021
Q3 | $43K | Hold |
3,644
| – | – | ﹤0.01% | 4444 |
|
|
2021
Q2 | $56K | Sell |
3,644
-15,141
| -81% | -$233K | ﹤0.01% | 4304 |
|
|
2021
Q1 | $451K | Buy |
18,785
+17
| +0.1% | +$408 | ﹤0.01% | 3741 |
|
|
2020
Q4 | $554K | Buy |
18,768
+1,203
| +7% | +$35.5K | ﹤0.01% | 3564 |
|
|
2020
Q3 | $268K | Buy |
17,565
+101
| +0.6% | +$1.54K | ﹤0.01% | 3756 |
|
|
2020
Q2 | $436K | Buy |
17,464
+678
| +4% | +$16.9K | ﹤0.01% | 3544 |
|
|
2020
Q1 | $343K | Buy |
16,786
+817
| +5% | +$16.7K | ﹤0.01% | 3537 |
|
|
2019
Q4 | $493K | Sell |
15,969
-377
| -2% | -$11.6K | ﹤0.01% | 3598 |
|
|
2019
Q3 | $545K | Sell |
16,346
-447
| -3% | -$14.9K | ﹤0.01% | 3485 |
|
|
2019
Q2 | $537K | Sell |
16,793
-251
| -1% | -$8.03K | ﹤0.01% | 3558 |
|
|
2019
Q1 | $489K | Sell |
17,044
-251
| -1% | -$7.2K | ﹤0.01% | 3562 |
|
|
2018
Q4 | $695K | Buy |
17,295
+1,978
| +13% | +$79.5K | ﹤0.01% | 3303 |
|
|
2018
Q3 | $715K | Buy |
15,317
+1,705
| +13% | +$79.6K | ﹤0.01% | 3449 |
|
|
2018
Q2 | $1.12M | Buy |
13,612
+9,924
| +269% | +$817K | ﹤0.01% | 3189 |
|
|
2018
Q1 | $154K | Buy |
+3,688
| New | +$154K | ﹤0.01% | 3971 |
|